CBPO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CBPO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-26), China Biologic Products Holdings's current share price is $119.99. China Biologic Products Holdings's E10 for the quarter that ended in Sep. 2020 was $2.83. China Biologic Products Holdings's Shiller PE Ratio for today is 42.40.
The historical rank and industry rank for China Biologic Products Holdings's Shiller PE Ratio or its related term are showing as below:
During the past years, China Biologic Products Holdings's highest Shiller PE Ratio was 50.87. The lowest was 30.23. And the median was 40.15.
CBPO's Shiller PE Ratio is not rankedE10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
China Biologic Products Holdings's adjusted earnings per share data for the three months ended in Sep. 2020 was $0.990. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $2.83 for the trailing ten years ended in Sep. 2020.
The historical data trend for China Biologic Products Holdings's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Biologic Products Holdings Quarterly Data | ||||||||||||||||||||
Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | |
Shiller PE Ratio | Get a 7-Day Free Trial | 31.24 | 44.34 | 42.26 | 39.47 | 37.55 |
For the Biotechnology subindustry, China Biologic Products Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, China Biologic Products Holdings's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where China Biologic Products Holdings's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
China Biologic Products Holdings's Shiller PE Ratio for today is calculated as
Shiller PE Ratio | = | Share Price | / | E10 |
= | 119.99 | / | 2.83 | |
= | 42.40 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Biologic Products Holdings's E10 for the quarter that ended in Sep. 2020 is calculated as:
For example, China Biologic Products Holdings's adjusted earnings per share data for the three months ended in Sep. 2020 was:
Adj_EPS | = | Earnings per Share (Diluted) | / | CPI of Sep. 2020 (Change) | * | Current CPI (Sep. 2020) |
= | 0.99 | / | 111.7000 | * | 111.7000 | |
= | 0.990 |
Current CPI (Sep. 2020) = 111.7000.
China Biologic Products Holdings Quarterly Data
Earnings per Share (Diluted) | CPI | Adj_EPS | |
201012 | -0.250 | 89.289 | -0.313 |
201103 | 0.230 | 91.154 | 0.282 |
201106 | 0.280 | 91.612 | 0.341 |
201109 | -0.370 | 92.711 | -0.446 |
201112 | 0.180 | 92.885 | 0.216 |
201203 | 0.440 | 94.367 | 0.521 |
201206 | 0.460 | 93.495 | 0.550 |
201209 | 0.500 | 94.482 | 0.591 |
201212 | 0.210 | 95.237 | 0.246 |
201303 | 0.530 | 96.372 | 0.614 |
201306 | 0.570 | 95.984 | 0.663 |
201309 | 0.530 | 97.332 | 0.608 |
201312 | 0.320 | 97.624 | 0.366 |
201403 | 0.690 | 98.600 | 0.782 |
201406 | 0.790 | 98.200 | 0.899 |
201409 | 0.760 | 98.900 | 0.858 |
201412 | 0.470 | 99.000 | 0.530 |
201503 | 0.870 | 99.900 | 0.973 |
201506 | 0.990 | 99.500 | 1.111 |
201509 | 0.820 | 100.500 | 0.911 |
201512 | 0.590 | 100.600 | 0.655 |
201603 | 0.940 | 102.200 | 1.027 |
201606 | 1.100 | 101.400 | 1.212 |
201609 | 1.010 | 102.400 | 1.102 |
201612 | 0.690 | 102.600 | 0.751 |
201703 | 1.060 | 103.200 | 1.147 |
201706 | 1.090 | 103.100 | 1.181 |
201709 | 1.110 | 104.100 | 1.191 |
201712 | -0.880 | 104.500 | -0.941 |
201803 | 0.920 | 105.300 | 0.976 |
201806 | 0.830 | 104.900 | 0.884 |
201809 | 0.940 | 106.600 | 0.985 |
201812 | 0.870 | 106.500 | 0.912 |
201903 | 0.940 | 107.700 | 0.975 |
201906 | 1.060 | 107.700 | 1.099 |
201909 | 1.210 | 109.800 | 1.231 |
201912 | 0.320 | 111.200 | 0.321 |
202003 | 1.360 | 112.300 | 1.353 |
202006 | 0.910 | 110.400 | 0.921 |
202009 | 0.990 | 111.700 | 0.990 |
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Thank you for viewing the detailed overview of China Biologic Products Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Zhijing Cbpo Liu | officer: Corporate Vice President | 19 CHAOYANG PARK ROAD 18/F, JIALONG INTERNATIONAL BUILDING BEIJING F4 100125 |
Sean Shao | director | 21ST FLOOR, EVERBRIGHT BANK BUILDING, ZHUZILIN, FUTIAN DISTRICT, SHENZHEN, GUANGDONG F4 518040 |
David Gao | director, officer: Chief Executive Officer | C/ BEIJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 |
Albert Yeung | director | C/O BEIJING MED-PHARM CORPORATION 600 WEST GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 |
David Hui Li | director | C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 |
Min Fang | director | UNIT 2206, BUND CENTER OFFICE TOWER NO. 222 YANAN ROAD (EAST) SHANGHAI F4 200002 |
Zhijun Tong | director | C/O BMP SUNSTONE CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 |
Joseph Chow | director | 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 |
Yungang Lu | director | 4TH FLOOR, ZHONGDIAN INFORMATION TOWER 6 ZHONGGUANCUN S. ST., HAIDIAN DIST. BEIJING F4 100086 |
Warburg Pincus Llc | 10 percent owner | 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Wp X Biologics Llc | director, 10 percent owner | C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK X1 10017 |
Warburg Pincus X Partners, L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus Private Equity X, L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus X Gp L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus X, L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
From GuruFocus
By PRNewswire PRNewswire • 08-18-2020
By PRNewswire PRNewswire • 05-12-2020
By [email protected] insider • 05-14-2020
By [email protected] insider • 11-15-2019
By PRNewswire PRNewswire • 03-13-2020
By [email protected] insider • 06-05-2020
By PRNewswire PRNewswire • 11-04-2019
By PRNewswire PRNewswire • 01-25-2021
By PRNewswire PRNewswire • 09-24-2019
By PRNewswire PRNewswire • 03-03-2020